(MENAFN- GlobeNewsWire - Nasdaq) Key opportunities in the Global Microfluidics Market include the rising demand for miniaturized, rapid point-of-care diagnostics, enhanced by AI and data analytics. Potential growth is driven by advancements in biomedical research and widespread support for accessible testing solutions in managing diseases.Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Microfluidics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets's offering.
The Global Microfluidics Market, valued at USD 29.10 Billion in 2024, is projected to experience a CAGR of 13.11% to reach USD 60.94 Billion by 2030
Microfluidics involves the precise manipulation of minute fluid volumes, typically at the nanoliter to picoliter scale, within micro-scale channels and chambers. The market's growth is primarily driven by the increasing demand for miniaturized diagnostic platforms, enabling rapid and efficient point-of-care testing. Additionally, advancements in biomedical research, particularly in areas requiring high-throughput screening and detailed cellular analysis, significantly contribute to market expansion.
The growing demand for point-of-care diagnostics significantly propels the microfluidics market by addressing the need for rapid, decentralized, and accessible testing solutions. This driver is particularly relevant in managing chronic diseases and infectious outbreaks, where timely, on-site results improve patient outcomes and healthcare efficiency.
Microfluidic technologies enable miniaturization and integration of complex diagnostic assays onto portable devices, allowing testing closer to the patient, even in resource-limited settings. The clear preference for these convenient methods is evident; according to OUCRU, in September 2024, a study published in Open Forum Infectious Diseases found that 96.5% of customers supported the future introduction of C-reactive protein point-of-care testing at pharmacies. This strong end-user endorsement underscores demand-side influence on innovation and adoption within the microfluidics sector.
Key Market Challenges
The complexity and high cost associated with microfluidic device fabrication represent a significant impediment to the widespread expansion of the Global Microfluidics Market. Manufacturing these intricate devices requires specialized processes, precision engineering, and often unique materials, which collectively elevate production expenses. This directly translates into higher unit costs for microfluidic products, making them less accessible for a broader range of applications and deterring potential commercial adoption across various industries.
Key Market Trends
Artificial Intelligence and Data Analytics Integration in Microfluidic Systems is a significant trend transforming the microfluidics market by enhancing the capabilities of device design, operation, and data interpretation. This integration allows for sophisticated analysis of complex biological data generated from microfluidic experiments, leading to improved accuracy and efficiency in various applications. According to Founders Forum Group, as of 2025, over 73% of organizations worldwide are either using or piloting AI in core functions, indicating a broad industry shift towards intelligent systems.
This widespread adoption facilitates the development of self-optimizing microfluidic platforms, accelerating research cycles and reducing human intervention. For example, Microsoft announced in September 2025 that it had successfully developed an in-chip microfluidic cooling system that leverages AI to identify unique heat signatures on a chip and direct coolant with more precision, enhancing heat removal by up to three times compared to traditional cold plates. This demonstrates AI's direct impact on optimizing the physical performance and sustainability of microfluidic components.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 182 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $29.1 Billion |
| Forecasted Market Value (USD) by 2030 | $60.94 Billion |
| Compound Annual Growth Rate | 13.1% |
| Regions Covered | Global |
Report Scope:
Key Market Players Profiled:
UFluidix Bio-Rad Laboratories Inc. Emulate Inc. Dolomite Microfluidics (Blacktrace Holdings Ltd) Sphere Fluidics Limited FluIdigm Corporation Illumina Inc. Micronit Microfluidics PerkinElmer Inc. Hesperos Inc.
By Technology:
Medical/Healthcare Non-medical
By Material:
Silicon Glass Polymer PDMS Others
By End User:
Lab-on-a-chip Organs-on-chips Continuous flow microfluidics Optofluidics and microfluidics Acoustofluidics and microfluidics Electrophoresis and microfluidics
By Region:
North America Europe Asia-Pacific South America Middle East & Africa
For more information about this report visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
CONTACT:
CONTACT:
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
![]()
MENAFN01122025004107003653ID1110420174
Comments
No comment